| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |